Tumour Size Is Not a Reliable Criterion for Resection of Patients with Non-Secreting Pancreatic Neuroendocrine Tumours: Results of an International, Multi-Centre, Operative Cohort Abstract #1777

Introduction: Small pancreatic neuroendocrine tumours (pNETs) present a management dilemma between surveillance and resection.
Aim(s): To assess the malignant characteristics of small pNETs in a retrospective, multicentre, operative patient cohort.
Materials and methods: Patients were identified from 5 hospitals using inclusion criteria of non-functional, non-familial, resected pNETs of all stages and grades. Logistic and cox regression were performed using SPSSv22.
Conference: 14th Annual ENETS conference 2017 (2017)
Category: Surgical treatment
Presenting Author: Logan Mills

To read results and conclusion, please login ...

Further abstracts you may be interested in

#1209 Pancreatic Neuroendocrine Incidentalomas: When is Surgery in the Patient’s Best Interests?
Introduction: Small PNETs, many of which are diagnosed incidentally, pose a management dilemma. Whilst resection offers curative outcomes, the risks of surgery have led many to adopt surveillance strategies. 2cm is often used as a threshold for malignancy, but reports suggest that this value may not be valid.
Conference: 12th Annual ENETS Conference 2015 (2015)
Category: Surgical treatment
Presenting Author: Logan Mills
Keywords: PNET
#1710 Observational Study of Small Pancreatic Neuroendocrine Incidentalomas: A Tertiary Referral Center Experience
Introduction: Incidence in small pancreatic neuroendocrine incidentalomas (PNETs-I) are increasing and its management remains controversial
Conference: 14th Annual ENETS conference 2017 (2017)
Category: Epidemiology/Natural history/Prognosis - Descriptive epidemiology
Presenting Author: Inmaculada Peiró Martínez
Keywords: PNETs
#3048 Somatostatin Analogs or Active Surveillance in Sporadic Non-Functioning Pancreatic Neuroendocrine Tumors
Introduction: Non-functioning (NF), sporadic pancreatic neuroendocrine tumors (pNETs) have usually an indolent behavior, but sometimes show an unpredictable aggressiveness. Surgery is the first-choice for localized tumors >2 cm. Unresectable or metastatic lesions expressing somatostatin receptors (SSTRs) are treated with Somatostatin analogs (SSAs). No evidence of SSAs efficacy exists in tumors ≤2 cm, for which active surveillance has been proposed.
Conference: 17th Annual ENETS Conference 2020 (2020)
Category: Medical treatment - Chemotherapy Somatostatin analogues, Interferon
Presenting Author: PhD Giovanni Schinzari
#650 Incidental Diagnosis as Prognostic Factor in Different Tumor-Stages of Non-Functioning Pancreatic Endocrine Tumors
Introduction: Although incidental diagnosis of non-functioning pancreatic endocrine tumors (NF-pNETs) is not an assurance of benign behavior, incidental NF-pNETs are associated with improved survival after resection.
Conference: 10th Annual ENETS Conference 2013 (2013)
Category: Epidemiology/Natural history/Prognosis - Prognosis
Presenting Author: Stefano Partelli
#1122 Clinicopathological Characteristics and Long Term Survival Analysis of Pancreatic Neuroendocrine Incidentalomas: An Experience of 39 Cases from a Single Chinese Institute
Introduction: Pancreatic incidentaloma was found by coincidence without specific presentation like pancreatogenic abdominal pain,palpable mass,obstructive jaundice and endocrine symptoms.The characteristics and prognosis of the tumor were rarely discussed.
Conference: 12th Annual ENETS Conference 2015 (2015)
Category: Surgical treatment
Presenting Author: MD Meng Wei
Authors: Leng J H, Wei M, Li Y, Chen Z, ...